| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
61,956 |
54,699 |
$4.96M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,011 |
15,703 |
$2.00M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14,662 |
14,281 |
$1.56M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,097 |
12,080 |
$1.55M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
43,704 |
30,647 |
$1.49M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,774 |
8,596 |
$1.00M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,203 |
9,027 |
$394K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,587 |
11,597 |
$170K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
15,679 |
15,195 |
$138K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,229 |
1,128 |
$130K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,460 |
1,388 |
$126K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17,676 |
16,332 |
$121K |
| 99383 |
|
791 |
777 |
$99K |
| 90670 |
|
7,508 |
7,127 |
$80K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17,529 |
16,624 |
$74K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
734 |
595 |
$66K |
| 99382 |
|
382 |
379 |
$49K |
| 99384 |
|
304 |
292 |
$44K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
4,385 |
4,165 |
$24K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
19,935 |
18,974 |
$20K |
| 90651 |
|
3,318 |
3,169 |
$10K |
| 90677 |
|
1,274 |
1,257 |
$10K |
| 92551 |
|
27,946 |
24,389 |
$9K |
| 0071A |
|
362 |
343 |
$9K |
| 99381 |
|
65 |
65 |
$9K |
| 0072A |
|
241 |
235 |
$7K |
| 87807 |
|
1,249 |
1,184 |
$6K |
| 90633 |
|
5,051 |
4,870 |
$5K |
| 90716 |
|
4,528 |
4,390 |
$4K |
| 90647 |
|
8,957 |
8,551 |
$4K |
| 90680 |
|
5,702 |
5,444 |
$3K |
| 90620 |
|
501 |
490 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
471 |
356 |
$2K |
| 99173 |
|
28,110 |
24,511 |
$2K |
| 90713 |
|
9,427 |
9,017 |
$2K |
| 90707 |
|
4,436 |
4,298 |
$2K |
| 99442 |
|
89 |
89 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
39 |
37 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
322 |
277 |
$2K |
| 90700 |
|
11,858 |
11,380 |
$1K |
| 90734 |
|
1,897 |
1,792 |
$963.36 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,323 |
1,270 |
$891.59 |
| 90619 |
|
665 |
656 |
$864.00 |
| 90744 |
|
4,351 |
4,184 |
$678.41 |
| 90686 |
|
3,166 |
3,031 |
$577.45 |
| 90621 |
|
1,160 |
1,041 |
$557.78 |
| 0001A |
|
28 |
28 |
$500.00 |
| 0124A |
|
14 |
14 |
$451.83 |
| 0002A |
|
13 |
13 |
$360.00 |
| 90685 |
|
426 |
395 |
$25.00 |
| 91307 |
|
711 |
625 |
$2.53 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$1.80 |
| 91300 |
|
170 |
164 |
$1.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
49 |
28 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
195 |
170 |
$0.00 |
| 90715 |
|
1,612 |
1,547 |
$0.00 |
| 90710 |
|
14 |
14 |
$0.00 |
| 91312 |
|
14 |
14 |
$0.00 |